<div id="readability-page-1"><p>Herbalife Ltd. (NYSE:HLF - Get Free Report)'s share price hit a new 52-week low during trading on Wednesday . The company traded as low as $5.95 and last traded at $5.97, with a volume of 3033895 shares changing hands. The stock had previously closed at $6.51.</p><h2>Wall Street Analysts Forecast Growth</h2><ul><li>3 Small Caps That Have Big Upside</li></ul><p>A number of research analysts recently issued reports on the company. Citigroup decreased their price objective on Herbalife from $16.00 to $13.00 and set a &#34;buy&#34; rating for the company in a report on Friday, October 25th. Mizuho raised their price target on shares of Herbalife from $8.00 to $9.00 and gave the stock a &#34;neutral&#34; rating in a research note on Friday, November 1st. DA Davidson lowered their price objective on shares of Herbalife from $13.00 to $7.50 and set a &#34;neutral&#34; rating on the stock in a report on Thursday, October 31st. B. Riley reduced their target price on shares of Herbalife from $17.00 to $12.00 and set a &#34;buy&#34; rating for the company in a report on Thursday, October 31st. Finally, StockNews.com upgraded shares of Herbalife from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research note on Monday, November 4th. One investment analyst  has rated the stock with a sell rating, two have issued  a hold rating and three have given a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of &#34;Hold&#34; and a consensus price target of $9.90.</p><p><b>View Our Latest Analysis on HLF</b></p><h2>Herbalife Stock Performance</h2><ul><li>3 Undervalued Midcaps Ready to Pop</li></ul><p>The firm has a fifty day moving average price of $7.04 and a 200 day moving average price of $7.89. The company has a market cap of $572.99 million, a price-to-earnings ratio of 6.69, a P/E/G ratio of 0.22 and a beta of 1.18. </p><p>Herbalife (NYSE:HLF - Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $0.57 EPS for the quarter, beating analysts' consensus estimates of $0.19 by $0.38. The firm had revenue of $1.24 billion during the quarter, compared to analysts' expectations of $1.23 billion. Herbalife had a net margin of 1.73% and a negative return on equity of 18.66%.  On average, analysts expect that  Herbalife Ltd. will post 1.51 EPS for the current fiscal year. </p><h2>Hedge Funds Weigh In On Herbalife</h2><ul><li>3 Defensive Stocks to Weather the Winter Storm</li></ul><p>A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Perpetual Ltd lifted its position in shares of  Herbalife by 107.1% in the fourth quarter. Perpetual Ltd now owns 966,063 shares of the company's stock valued at $6,463,000 after buying an additional 499,572 shares during the last quarter.  Barclays PLC lifted its holdings in  Herbalife by 347.0% during the 3rd quarter. Barclays PLC now owns 161,426 shares of the company's stock valued at $1,160,000 after purchasing an additional 125,311 shares during the last quarter.  UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in  Herbalife by 72.1% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 168,209 shares of the company's stock worth $1,209,000 after purchasing an additional 70,498 shares during the period.  Charles Schwab Investment Management Inc. increased its holdings in shares of  Herbalife by 6.9% in the third quarter. Charles Schwab Investment Management Inc. now owns 2,479,957 shares of the company's stock valued at $17,831,000 after purchasing an additional 160,792 shares during the last quarter.  Finally, Geode Capital Management LLC raised its position in shares of  Herbalife by 4.2% in the third quarter. Geode Capital Management LLC now owns 2,615,514 shares of the company's stock valued at $18,809,000 after purchasing an additional 105,431 shares during the period. </p><h2>Herbalife Company Profile</h2> (Get Free Report)<p>Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Herbalife</li><li>Options Trading - Understanding  Strike Price</li><li>How Growth Investors Find High-Growth Stocks and Maximize Returns</li><li>How to Choose Top Rated Stocks</li><li>Meta’s AI &amp; Smart Glasses Could Drive 20%+ Upside in 2025</li><li>3 Grocery Stocks That Are Proving They Are Still Essential </li><li>NVIDIA's Slide Continues: Can Retail Investors Stop the Fall?</li></ul><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Herbalife Right Now?</h2><p>Before you consider Herbalife, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Herbalife wasn't on the list.</p><p>While Herbalife currently has a &#34;Hold&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Herbalife Ltd. (NYSE:HLF) shares hit a new 52-week low of $5.95, closing at $5.97 with a trading volume of 3,033,895. Analysts have mixed ratings, with Citigroup lowering its price target to $13.00, while Mizuho raised it to $9.00. The stock has a consensus rating of "Hold" and a price target of $9.90. Herbalife reported $0.57 EPS, exceeding estimates, with revenue of $1.24 billion. Institutional investors have increased their stakes in the company, which specializes in health and wellness products globally.</p>

Herbalife (NYSE:HLF) Reaches New 12-Month Low - Here's What Happened